View Information Collection Request (ICR) Package

OMB Control No: 0938-1026	ICR Reference No: 201403-0938-006
Status: Historical Active	Previous ICR Reference No: 201011-0938-016
Agency/Subagency: HHS/CMS	Agency Tracking No: 21549
Title: Medicaid Payment for Prescription Drugs - Physicians and Hospital Outpatient Departments Collecting and Submitting Drug Identifying Information to State Medicaid Programs (CMS-10215)
Type of Information Collection: Reinstatement without change of a previously approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 04/14/2014
	Date Received in OIRA: 03/12/2014
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	04/30/2017	36 Months From Approved
Responses	3,910,000	0	0
Time Burden (Hours)	16,227	0	0
Cost Burden (Dollars)	0	0	0

Abstract: Section 6002 of the Deficit Reduction Act (DRA) of 2005 added provisions under section 1927 of the Social Security Act to require physicians in their offices and hospital outpatient settings or other entities (e.g., non-profit facilities) to collect and submit the drug National Drug Code (NDC) numbers on Medicaid claims to their State in order for Federal Financial Participation to be available for these drugs. We estimate that there are 20,000 physicians in their offices, hospital outpatient settings or other entities (e.g., non-profit facilities) concentrating in the specialties of oncology, rheumatology and urology will be required by their State Medicaid Programs to collect and submit Healthcare Common Procedure Coding System (HCPC) J drug code data match with NDC numbers. CMS released a letter to State Medicaid Directors on July 11, 2006 to explain the requirements of the State collection and submission of the drug NDC numbers on Medicaid claims. This collection is also associated with CMS-2238-FC Medicaid Program: Prescription Drugs published under Volume 72, Number 136, Tuesday, July 17, 2007, Rules and Regulations (RIN 0938-AO20). The requirements for this collection are codified under 42 Code of Federal Regulations section 447.520 Federal Financial Participation: Conditions relating to physician administered drugs.

Authorizing Statute(s): PL: Pub.L. 109 - 171 6002 Name of Law: Deficit Reduction Act of 2005

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	78 FR 78967	12/27/2013
30-day Notice:	Federal Register Citation:	Citation Date:
	79 FR 13059	03/07/2014
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Change Due to Potential Violation of the PRA
Annual Number of Responses	3,910,000	3,910,000
Annual Time Burden (Hours)	16,227	16,227
Annual Cost Burden (Dollars)	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov

View ICR - OIRA Conclusion